Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

0.9386 -0.0614 (-6.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen Inc

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
From Law Offices of Howard G. Smith
Via Business Wire
Notice of Lead Plaintiff Deadline for Shareholders in the Ocugen, Inc. Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
2 Stocks That Are Running Circles Around Bitcoin This Year
Can they keep outpacing the popular cryptocurrency? 
Via The Motley Fool
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
ONGOING INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ocugen, Inc. (OCGN) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Ocugen, Inc. (OCGN) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ocugen, Inc. (OCGN) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
It’s Time to Admit Defeat and Dump Ocugen Stock as a Covid Play
After the FDA rejected Covaxin, Ocugen has almost no chance of generating profits from the shot. OCGN stock is a great short. 
Via InvestorPlace
Exposures Product Safety
24 Stocks Moving in Wednday's Pre-Market Session
Gainers Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) rose 43.6% to $2.93 in pre-market trading after a 13G filing from Ra Capital showed a 7.5% stake in the company. Greenland... 
Via Benzinga
Avoid These 3 Overvalued Reddit Stocks
Reddit stocks Tilray, Inc., Clover Health Investments, Corp., and Ocugen, Inc., which are currently trading at high valuations, are examples of Reddit stocks that we think could retreat in the... 
Via Talk Markets
Novavax COVID-19 Vaccine Could Become Available In India By September, Says Partner
Novavax Inc (NASDAQ: NVAX) COVID-19 vaccine, marketed as "Covovax," could see a launch in India as early as September, Moneycontrol reported on Wednesday... 
Via Benzinga
Exposures COVID-19
OCGN Stock: Ocugen Fans Should Be Cheering This COVAXIN News
OCGN stock saw a glimmer of hope today. Where the company took a hit last week in deserting EUA, it is gaining today with a new partnership. 
Via InvestorPlace
Exposures COVID-19 Product Safety
Why Ocugen Stock Rallied Today
The biotech is bolstering its production capabilities for an experimental coronavirus vaccine. 
Via The Motley Fool
Exposures COVID-19
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers HMG/Courtland Properties, Inc. (NYSE: HMG) shares surged 133% to $27.80. Alfi, Inc. (NASDAQ: ALF) shares jumped 82.1% to $6.21 after the company inked an agreement with... 
Via Benzinga
Ocugen Stock Jumps After Recruiting Jubilant HollisterStier As Manufacturing Partner For COVID-19 Vaccine Candidate
Ocugen Inc (NASDAQ: OCGN) has selected Jubilant HollisterStier of Spokane, Washington as its manufacturing partner for COVID-19 vaccine candidate, Covaxin for the... 
Via Benzinga
Exposures COVID-19
Thinking About Buying Stock Or Options In Royal Caribbean Group, Ocugen Or Spirit Airlines?
Royal Caribbean Cruises Ltd (NYSE:RCL) Tuesday announced that... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Clearside Biomedical (NASDAQ:CLSD) stock increased by 50.99% to $4.56 during Tuesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
Ocugen Stock Crashes: What Should Investors Do Now?
Here are three steps to take. 
Via The Motley Fool
Exposures COVID-19 Product Safety
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Will This News Stop Ocugen Shares in Their Tracks?
This high flyer is still up more than 260% this year. 
Via The Motley Fool
Exposures COVID-19
Where Will Ocugen Be in 1 Year?
This biotech underdog's dream of selling a coronavirus vaccine in the U.S. just went up in smoke. 
Via The Motley Fool
Exposures COVID-19
OCUGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Ocugen, Inc. on Behalf of Ocugen Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to... 
Via Benzinga
10 Biggest Price Target Changes For Friday
Barclays lowered Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading.... 
Via Benzinga
Why Ocugen Plummeted by Nearly 30% Today
The company won't be getting emergency use authorization for Covaxin after all. 
Via The Motley Fool
Exposures COVID-19 Product Safety
66 Biggest Movers From Yesterday
Gainers Orphazyme A/S (NASDAQ: ORPH) shares jumped 302.3% to close at $21.00 on Thursday. Shares of the biopharmaceutical firm touched an intraday high of $77.77, running up 1,... 
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.